Mylan
Mylan shells out $32.5m to cover tax inversion fines
December 11, 2014Sales and Marketing AbbVie, Abbott, Mylan, SEC, bresch, coury
Mylan will pay five of its top executives an early $32.5 million to cover penalties from the company’s plans to …
Mylan buys Abbott generics
July 15, 2014Manufacturing and Production, Sales and Marketing Abbott, Mylan, generics, new mylan
Abbott is to sell the portion of its branded generics business which operates in developed markets such as Europe to …
Servier fined €331m by European Commission
July 10, 2014Sales and Marketing EC, European Commission, France, Krka, Lupin, Matrix, Mylan, Niche/Unichem, Servier, Teva
The European Commission has served French pharma company Servier with a €331 million fine for delaying the entry to market …
Celgene ‘stops Mylan entering market’
April 6, 2014Sales and Marketing Celgene, Mylan, Revlimid, myeloma
Generic manufacturer Mylan is suing Celgene in a spat over allowing copycat versions of existing cancer drugs – Revlimid and …
India court grants Herceptin injunction
February 10, 2014Research and Development, Sales and Marketing Biocon, Herceptin, India, Mylan, Roche
Roche has been granted an injunction by a court in India to prevent generic manufacturers of its ageing breast cancer …
High-dose Copaxone the right medicine for Teva
January 29, 2014Research and Development, Sales and Marketing Biogen, Copaxone, FDA, MS, Mylan, Teva
The FDA has approved a high-dose version of Teva’s multiple sclerosis drug Copaxone which will help the firm offset approaching …
Mylan hires president of European business
October 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, glinka
Mylan has announced that from December Jacek Glinka will be the president of its European business. Glinka served as chief …
Manufacturing and production news in brief
September 6, 2013Manufacturing and Production GSK, Jabones Pardo, Mylan, Shasun, Wockhardt
A round-up of pharma manufacturing facility news, with updates from Wockhardt, Mylan, GSK and Shasun, plus an FDA warning letter …
Roger Graham appointed president of Mylan Specialty
June 25, 2013Manufacturing and Production, Research and Development, Sales and Marketing Mylan, graham, specialty
Mylan has hired previous J&J vice president Roger Graham to be president of its specialty business. Graham will report to …
Insulin blockbusters targeted by biosimilar blitz
February 15, 2013Research and Development, Sales and Marketing Biocon, Humalog, Mylan, insulin
Mylan and Biocon are the latest companies to announce major new plans to develop and market biosimilars. The firms are …
Mylan appoints two heads to Board of directors
February 12, 2013Manufacturing and Production, Research and Development, Sales and Marketing Mylan
Mylan has announced the appointment of Melina Higgins, a former partner at Goldman Sachs, and Rajiv Malik, currently Mylan’s president, …
Mylan buys Indian oncology plant for $33m
October 18, 2012Manufacturing and Production API, Mylan, SMS
Indian contract research and manufacturing services (CRAMS) company SMS Pharmaceuticals has sold its manufacturing facility in Andhra Pradesh to US …
Pfizer and Mylan sign Japanese generics deal
August 23, 2012Sales and Marketing Mylan, Pfizer, generics
Pfizer and Mylan have struck a deal to sell generic drugs together in Japan, the world’s second biggest pharma market. …
Generic Actos gains FDA approval
August 20, 2012Sales and Marketing Actos, Mylan, Ranbaxy, Takeda, diabetes, generic
Takeda’s big-selling diabetes pill Actos will have its US sales decimated after the FDA approves three copycat versions of the …
Mylan earmarks €380m for Irish expansion
April 24, 2012Manufacturing and Production Galway, Ireland, Mylan, manufacturing and production
Generic drugmaker Mylan has announced a plan to invest €380 million in its operations in the Republic of Ireland, including …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
